A carregar...
Bevacizumab in metastatic breast cancer: when may it be used?
Tumor angiogenesis, which is necessary for breast cancer growth, invasion and metastases, is regulated by pro-angiogenic factors such as vascular endothelial growth factor (VEGF). Bevacizumab is a recombinant humanized monoclonal antibody that targets VEGF. The addition of bevacizumab to chemotherap...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2011-03-01
|
| Colecção: | Therapeutic Advances in Medical Oncology |
| Acesso em linha: | https://doi.org/10.1177/1758834010397627 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|